June 2023
-
06.13.2023 Updates & Statements Diseases & Conditions Migraines Partnerships Lady Gaga Partners with Pfizer to Raise Migraine Awareness -
06.01.2023 Events Diversity & Inclusion Pfizer Culture 2023 Pride Journal—Stronger Together
May 2023
-
05.26.2023 Vaccines Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with the European Commission -
05.18.2023 Covid-19 Partnerships Research Research!America Offers $200k Discovery | Innovation | Health Prize for COVID-19 Innovator -
05.16.2023 Events Diversity & Inclusion Employees Pfizer Culture Events in NYC and Italy Spotlight Disability Inclusion -
05.11.2023 Covid-19 Diseases & Conditions Health Equity Vaccines Global and U.S. Agencies Declare End of COVID-19 Emergency -
05.05.2023 Business Employees Leadership Pfizer Culture Pfizer Sets New Ambition: Changing a Billion Lives a Year by 2027
December 2022
-
12.15.2022 Health Equity Partnerships Responsibility Health Equity in Action Summit 2022 Recap: Themes Emerge for Addressing Systemic Racism in Healthcare
November 2021
-
11.30.2021 Responsibility One Year Later: Pfizer Update on Progress of Humanitarian Assistance Program
September 2021
-
09.16.2021 Perspectives Albert Bourla Covid-19 Diseases & Conditions Vaccines Continuing to Follow the Science: An Open Letter from Pfizer Chairman and CEO Dr. Albert Bourla
May 2021
-
05.07.2021 Perspectives Albert Bourla Covid-19 Diseases & Conditions Vaccines An Open Letter from Pfizer Chairman and CEO to Colleagues
March 2021
-
03.09.2021 Perspectives Albert Bourla Business Clinical Trials Covid-19 Diseases & Conditions Leadership mRNA Partnerships Patient Centricity Technology Vaccines Wellness Albert Bourla Reflects on the One Year Anniversary of the COVID-19 Pandemic